The ITV regular told his Instagram followers that obesity is driven by biology, not willpower, and that patients choose these drugs with their doctors. Followers replied with their own results.
Recap by typeshit. Full story at The Mirror.
An investing platform's company history runs from Lilly's 1876 founding through Humulin and Prozac to its obesity drug boom. Background, not news.
Generic advice that a lack of hunger doesn't mean you've eaten enough, with a nudge toward smaller portions built around protein.
Dr. Mimi Tan points to a wider set of obesity treatments and notes Ozempic is the semaglutide brand meant for type 2 diabetes.
Brian Underwood shares that the Men's Health fall issue starring Drake Maye is on newsstands, with peptides among the topics inside.
Researchers found self-reported GLP-1 use climbed from March 2024 to October 2025, mostly for weight loss, through channels insurance data may not capture.
Trell argues a toned lower body comes from lean muscle, crediting weekly strength training and recovery fuel rather than Ozempic or peptides.
Loading…